510(k) K200876

Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program Continuous Glucose Monitoring System by Dexcom, Inc. — Product Code QBJ

K200876 is an FDA 510(k) premarket notification submitted by Dexcom, Inc. for the device "Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program Continuous Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Dec 4, 2020. The device falls under product code QBJ (Integrated Continuous Glucose Monitoring System, Factory Calibrated), a Class II device regulated under 21 CFR 862.1355. Dexcom, Inc. has 27 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 4, 2020
Date Received
Apr 1, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Integrated Continuous Glucose Monitoring System, Factory Calibrated
Device Class
Class II
Regulation Number
862.1355
Review Panel
CH
Submission Type
510(k)

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.

Need the full FDA record for Dexcom, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K200876. Report a data issue: hello@regdatalab.com.